Healthcare advertisers have access to enormous amounts of claims and clinical data, but turning those signals into usable media decisions remains difficult. Chalice AI and PurpleLab are partnering to address that gap by combining real-world healthcare intelligence with custom predictive modeling designed around specific patient, prescriber and business outcomes.
The partnership brings together PurpleLab’s healthcare analytics infrastructure, which covers more than 330 million U.S. patient lives and over 3 million healthcare professionals, with Chalice AI’s platform-independent media decisioning technology.
Instead of starting with a predefined audience segment, the companies say marketers will be able to begin with the outcome they want to influence and build a predictive model around it. Potential applications include identifying prospective patients, finding prescriber opportunities, predicting treatment adoption and estimating attrition.
That represents a notable shift in healthcare advertising. Traditional audience planning often depends on demographic characteristics, broad behavioral signals or predefined clinical segments. Predictive modeling takes a different approach: it attempts to identify people or professionals based on their estimated likelihood of producing a particular advertiser-defined outcome.
PurpleLab provides the underlying longitudinal medical and pharmacy claims signals. Chalice then uses those signals to develop custom models that can inform media decisioning and audience activation.
The distinction is important because healthcare advertising operates under tighter privacy and compliance constraints than many consumer advertising categories. Medical and prescription-related information cannot simply be treated like conventional retail behavioral data. Data provenance, permitted use, security and transparency are therefore central to whether predictive advertising models can move from experimentation into scaled deployment.
The companies say models will be developed in secure, privacy-first environments, while marketers retain visibility into the categories and provenance of data informing the models and the methodology used to translate those signals into media decisions.
If the approach works at scale, its significance could extend beyond audience targeting. A model predicting treatment adoption, for example, could potentially inform not only who receives an advertisement but also how a campaign is structured, which creative is used and where media investment is concentrated.
Chalice says these models can be activated across connected TV, social platforms and the open internet. That platform-independent approach is significant in an increasingly fragmented advertising market, where marketers often manage separate targeting and measurement systems across Google, Meta, CTV platforms and programmatic exchanges.
The competitive landscape includes healthcare data companies, identity providers, clean-room technologies, demand-side platforms and audience intelligence vendors. Large advertising ecosystems such as Google and Amazon increasingly use machine learning for audience prediction and media optimization, while specialist healthcare platforms compete on the depth, quality and permissible use of clinical data.
Chalice and PurpleLab are attempting to differentiate through the combination of proprietary healthcare intelligence and advertiser-specific predictive models rather than a universal audience taxonomy.
For enterprise healthcare marketers, however, model accuracy will not be the only consideration. The ability to explain why an audience was selected, establish the provenance of the underlying signals and demonstrate that data was used appropriately may be just as important as predictive performance.
The partnership therefore points toward a broader evolution in healthcare AdTech: moving from buying media against static healthcare audiences toward using outcome-oriented models to determine where advertising investment should go.
The promise is greater precision. The operational challenge will be proving that precision without sacrificing transparency, privacy or regulatory control.
Market Landscape
Healthcare advertising is increasingly becoming a data and measurement problem. Pharmaceutical companies and healthcare marketers need to reach highly specific patient and HCP populations while navigating privacy requirements and fragmented media environments.
Predictive modeling can potentially bridge the gap between real-world healthcare data and media activation. Rather than simply identifying people who match an existing condition or demographic profile, models can be trained around advertiser-defined outcomes such as patient acquisition, prescribing behavior or retention.
The broader advertising market is moving in the same direction. AI is increasingly being used to automate audience selection, bidding, creative optimization and campaign measurement. The healthcare sector adds another layer of complexity because data provenance and permitted use must remain visible throughout the workflow.
For marketers, the most important development may therefore be the emergence of custom models that can be applied across channels rather than isolated targeting products tied to individual media platforms.
Top Insights
- Chalice AI and PurpleLab combine healthcare claims intelligence with custom predictive models designed around patient, prescriber and advertiser-defined business outcomes.
- The partnership moves healthcare audience planning beyond static segments toward predictive audiences based on estimated likelihood of specific outcomes.
- PurpleLab contributes longitudinal medical and pharmacy claims data, while Chalice translates healthcare signals into media decisioning and activation.
- Models can be activated across CTV, social platforms and the open internet, giving healthcare marketers a cross-channel predictive audience strategy.
- Privacy, security, data provenance and model transparency remain critical adoption requirements as AI becomes more deeply embedded in healthcare advertising.
Get in touch with our Adtech experts.
